Safety and tolerability of fingolimod in relapsing- remitting multiple sclerosis: resuls from a large open-label clinical trials.

Publication date

January 2018

Abstract

none12nononeA. Laroni; D. Brogi; V. Brescia Morra; L. Guidi; C. Pozzilli; G. Comi; A. Lugaresi; R. Turrini; D. Raimondi; A. Uccelli; GL Mancadi; EAP InvestogatorsA. Laroni; D. Brogi; V. Brescia Morra; L. Guidi; C. Pozzilli; G. Comi; A. Lugaresi; R. Turrini; D. Raimondi; A. Uccelli; GL Mancadi; EAP Investogator

Extracted data

We use cookies to provide a better user experience.

Data Protection

Safety and tolerability of fingolimod in relapsing- remitting multiple sclerosis: resuls from a large open-label clinical trials.

Open link

Publication date

January 2018

Safety and tolerability of fingolimod in relapsing- remitting multiple sclerosis: resuls from a large open-label clinical trials.

Abstract

Extracted data

Safety and tolerability of fingolimod in relapsing- remitting multiple sclerosis: resuls from a large open-label clinical trials.

Abstract

Extracted data

Related items

Related items